Mylan (MYL) Affirms FY14 EPS Outlook, Comments on Teva Patent Litigation Appeal
Tweet Send to a Friend
Mylan Inc. (Nasdaq: MYL) announced that the Supreme Court of the United States granted certiorari in Mylan's patent litigation against ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE